A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users

1999/11/19 by Miriam Z. Mintzer, M. Z. Mintzer, KennethP Stoller +2 · 41 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · Psychology · #Alprazolam #Anesthesia #Antagonist #Anxiety #Benzodiazepine #Coffee research and impacts #Diazepam #Flumazenil #Forensic Toxicology and Drug Analysis #Internal medicine #Medicine #Nausea #Placebo #Psychiatry #Psychology #Sleep and related disorders

paper · doi:10.1007/s002130051161

published in Psychopharmacology 147(2), 200-209 (Springer Science and Business Media LLC)

crossref issued 1999/11/19 · crossref published 1999/11/19 · crossref published-print 1999/11/19 · openalex publication_date 1999/11/19 · crossref created 2002/08/25 · crossref deposited 2019/05/23 · openalex created_date 2025/10/10 · crossref indexed 2026/06/18 · openalex updated_date 2026/08/01

Citations

• Benzodiazepine Withdrawal: outcome in 50 patients

Cited by

• Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure
• Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
• Imidazenil: An antagonist of the sedative but not the anticonvulsant action of diazepam
• Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo‐controlled study
• Benzodiazepine withdrawal syndrome [wikipedia]